SNSS Financial Facts

Other income (expense), net: 23K
License and other revenue: 610K
See Full Income Statement

Accrued compensation: 1.11M
Total current assets: 33.95M
See Full Balance Sheet

Sunesis Pharmaceuticals Inc. (SNSS) Earnings

  |   Expand Research on SNSS
Next EPS Date 3/10/17 *Est. EPS Growth Rate -588.9% *Last Qtr.
Average EPS % Beat Rate -3.6% Revenue Growth Rate -14.3% *Last Qtr.
Average % Move 1-Wk after EPS -20.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/3/16 Q316 -$0.62-$0.71 +$0.09$600K$600K N/A Details
7/29/16 Q216 -$0.12-$0.10 -$0.02$610K$1.03M N/A Details
5/5/16 Q116 -$0.12-$0.12 $0.00$600K$1K N/A Details
3/10/16 Q415 -$0.15-$0.14 -$0.01$670K$700K N/A Details
11/5/15 Q315 -$0.09-$0.15 +$0.06$700K$1.09M N/A Details
7/30/15 Q215 -$0.15-$0.13 -$0.02$854K$1.21M N/A Details
5/5/15 Q115 -$0.13-$0.16 +$0.03$854K$980K N/A Details
3/12/15 Q414 -$0.02-$0.19 +$0.17$896K$1.17M N/A Details